Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: A randomized controlled trial

Journal of ECT

Volumn 29, Issue 2, 2013, Pages 86-92

  Nordenskjold, Axel ^a,b   Von Knorring, Lars ^a,c   Ljung, Tomas ^d   Carlborg, Andreas ^e,f   Brus, Ole ^a,g   Engstrom, Ingemar ^a,b  

^a Orebro County Council   (Sweden)

^b ÖREBRO UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d Clinic of Psychiatry   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f DANDERYD HOSPITAL   (Sweden)

^g ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Electroconvulsive therapy; Major depressive disorder; Treatment outcome

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; MIRTAZAPINE; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ALZHEIMER DISEASE ASSESSMENT SCALE; ARTICLE; BIPOLAR DEPRESSION; CLINICAL EFFECTIVENESS; COGNITION; CONTROLLED STUDY; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH CARE; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; POST HOC ANALYSIS; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUICIDE; SWEDEN;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIMANIC AGENTS; COGNITION; COMBINED MODALITY THERAPY; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LITHIUM; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84880136961     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e318276591f     Document Type: Article

References (31)

1. Sobocki P, Lekander I, Borgstrom F, et al. The economic burden of depression in Sweden from 1997 to 2005. Eur Psychiatry. 2007;22:146-152.
2. Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr. 1995;146:5-16.
3. SBU. Treatment of Depression (Behandling av depressionssjukdomar). Stockholm: The Swedish Council on Technology Assessment in Health Care; 2004.
4. Huuhka M, Korpisammal L, Haataja R, et al. One-year outcome of elderly inpatients with major depressive disorder treated with ECT and antidepressants. J ECT. 2004;20:179-185.
5. Stoudemire A, Hill CD, Dalton ST, et al. Rehospitalization rates in older depressed adults after antidepressant and electroconvulsive therapy treatment. J Am Geriatr Soc. 1994;42:1282-1285.
6. American Psychiatric Association. Committee on electroconvulsive therapy. In: Weiner RD, ed. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging: A Task Force Report of the American Psychiatric Association. 2nd ed. Washington, D.C.: American Psychiatric Association; 2001.
7. Nordenskjold A, von Knorring L, Engstrom I. Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: a population-based cohort study. Depress Res Treat. 2011;2011:470985.
8. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299-1307.
9. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63:1337-1344.
10. Tew JD Jr, Mulsant BH, Haskett RF, et al. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Ann Clin Psychiatry. 2007;19:1-4.
11. Rabheru K. Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how? J ECT. 2012;28:39-47.
12. Nordenskjold A, von Knorring L, Engstrom I. Rehospitalization rate after continued electroconvulsive therapyVa retrospective chart review of patients with severe depression. Nord J Psychiatry. 2011;65:26-31.
13. Martinez-Amoros E, Cardoner N, Soria V, et al. Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy. J ECT. 2012;28:92-97.
14. Navarro V, Gasto C, Torres X, et al. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. Am J Geriatr Psychiatry. 2008;16:498-505.
15. Sartorius A, Wolf J, Henn FA. Lithium and ECTVconcurrent use still demands attention: three case reports. World J Biol Psychiatry. 2005;6:121-124.
16. Sackeim HA, Prudic J, Fuller R, et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32:244-254.
17. Hammar A, Ardal G. Cognitive functioning in major depressionVa summary. Front Hum Neurosci. 2009;3:26.
18. Smith GE, Rasmussen KG Jr, Cullum CM, et al. A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study. J Clin Psychiatry. 2010;71:185-193.
19. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
20. Svanborg P, Asberg M. A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand. 1994;89:21-28.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
22. Mohs RC, Cohen L. Alzheimer's Disease Assessment Scale (ADAS). Psychopharmacol Bull. 1988;24:627-628.
23. Guy W. ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute of Health, Psychopharmacology Research Branch; 1976:217-222.
24. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33; quiz 34-57.
25. Rush AJ, Thase ME, Dube S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry. 2003;53:743-753.
26. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17:244-253.
27. O'Connor MK, Knapp R, Husain M, et al. The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry. 2001;9:382-390.
28. Nordenskjold A, von Knorring L, Engstrom I. Predictors of the short-term responder rate of Electroconvulsive therapy in depressive disordersVa population based study. BMC Psychiatry. 2012;12:115.
29. Munk-Olsen T, Laursen TM, Videbech P, et al. All-cause mortality among recipients of electroconvulsive therapy: register-based cohort study. Br J Psychiatry. 2007;190:435-439.
30. Bradvik L, Berglund M. Long-term treatment and suicidal behavior in severe depression: ECT and antidepressant pharmacotherapy may have different effects on the occurrence and seriousness of suicide attempts. Depress Anxiety. 2006;23:34-41.
31. Lisanby SH, Sampson S, Husain MM, et al. Toward individualized post-electroconvulsive therapy care: piloting the Symptom-Titrated, Algorithm-Based Longitudinal ECT (STABLE) intervention. J ECT. 2008;24:179-182.